Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NAA25 |
| Upstream (Parents) |
|---|
| (<<) CCAR1 → NAA25 |
| (<<) REV3L → NAA25 |
| (<<) N4BP2L2 → NAA25 |
| (<<) JMJD1C → NAA25 |
| (<<) PSMB7 → NAA25 |
| (<<) MED6 → NAA25 |
| Downstream (Children) |
|---|
| NAA25 → NCRNA00201 (>>) |
| NAA25 → CCAR1 (>>) |
| NAA25 → GRAMD3 (>>) |
| NAA25 → REV3L (>>) |
| NAA25 → JMJD1C (>>) |
| NAA25 → LOC100128508 (>>) |
| NAA25 → FNBP1 (>>) |
| NAA25 → RPS24 (>>) |
| NAA25 → TMF1 (>>) |
| NAA25 → FUBP1 (>>) |
| NAA25 → SP3 (>>) |
| NAA25 → DDX50 (>>) |
| NAA25 → EIF3M (>>) |
| NAA25 → HNRNPA1 (>>) |
| NAA25 → MYSM1 (>>) |
| NAA25 → PRO2852 (>>) |
| NAA25 → MTMR9 (>>) |
| NAA25 → NSMCE4A (>>) |
| NAA25 → LOC100130930 (>>) |
| NAA25 → WDR33 (>>) |
